Celltrion Healthcare Competitors and Similar CompaniesClear all
Celltrion Healthcare's competitors and similar companies include CureVac and Candel Therapeutics.
 Celltrion Healthcare Celltrion Healthcare is a biopharmaceutical company specializing in oncology, influenza, psoriasis, and arthritis., |  Candel Therapeutics Candel Therapeutics (formerly known as Advantagene) is a biopharmaceutical company developing cancer immunotherapies. | ||
Founding Date | Founding Date 2002 | Founding Date 2000 | Founding Date 1999 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Incheon, KR HQ | Locations Tübingen, DE HQ Ottignies Louvain La Neuve, BE Wiesbaden, DE Amsterdam, NL Basel, CH Boston, US | Locations Needham, US HQ |
Employees | Employees 6301% increase | Employees 82517% decrease | Employees 50 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 648.3 m | Valuation ($) 176.8 m |
Financial | |||
Revenue (est.) | Revenue (est.) ₩2t (FY, 2022) | Revenue (est.) €535.2m (FY, 2024) | Revenue (est.) N/A |
Cost of goods | Cost of goods ₩1.4t (FY, 2022) | Cost of goods €9.7m (FY, 2024) | Cost of goods N/A |
Gross profit | Gross profit ₩664.7b (FY, 2022) | Gross profit €534.4m (FY, 2024) | Gross profit N/A |
Net income | Net income ₩147.2b (FY, 2022) | Net income €162.2m (FY, 2024) | Net income ($38.2m) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised N/A | Total funding raised $ 1.1b | Total funding raised $ 64.6m |
For sources of this data, please see the company profile
View Company Profiles
CureVac
HQ
Tübingen, DE
Employees
825↓ 17% decrease
CureVac is a biotechnology company offering messenger RNA (mRNA) technology.
View companyCandel Therapeutics
HQ
Needham, US
Employees
50
Candel Therapeutics (formerly known as Advantagene) is a biopharmaceutical company developing cancer immunotherapies.
View company